Ascension Capital Advisors »

SPDR S&P Biotech shares owned by Ascension Capital Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Ascension Capital Advisors from 13F filings

Historical chart of Ascension Capital Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Ascension Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Ascension Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 9.2k 121.93

More positions owned by Ascension Capital Advisors

First Tr Exchange Traded Risng Divd Achiv (RDVY)
Profesionally Managed Portfo Akre Focus Etf (AKRE)
Federated Hermes Etf Trust Us Strategic Div (FDV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ark Etf Tr Innovation Etf (ARKK)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Simplify Exchange Traded Fun Simplify Opport (CRDT)
Ishares Tr Residential Mult (REZ)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Exxon Mobil Corporation (XOM)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Ishares Tr S&P SML 600 GWT (IJT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Microsoft Corporation (MSFT)

View all positions for Ascension Capital Advisors

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech